Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors

Matthew A. Murray(Yale University), Ranjit S. Bindra(Yale University)
Molecular Cancer Therapeutics
May 1, 2024
10.1158/1535-7163.mct-24-0012
Cited by 6

Related Papers

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma
|Scientific Reports|2022|23
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion
|Molecular Cancer Research|2024|5
PARG inhibition induces nuclear aggregation of PARylated PARP1
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0